TPG Inc Class A TPG 深 滬
已收盤 04-02 16:00:00 美东时间
38.49
-0.460
-1.18%
華盛通- 最 高39.33
- 今 開37.86
- 成交量 265.94万股
- 最 低 36.95
- 昨 收 38.95
- 總市值 147.87亿
- 52周最高 69.77
- 市盈率 靜 85.76
- 換手率 0.69%
- 52周最低 36.95
- 委 比 -33.42%
- 總股本 3.84亿
- 歷史最高 70.39
- 量 比 1.13
- 振 幅 6.11%
- 歷史最低 16.80
- 每 手 1
- 風險率 7.75%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅499.25%！Cabaletta Bio获Guggenheim升目标价至16美元，维持"买入"评级
今日重点评级关注：Guggenheim：维持Cabaletta Bio"买入"评级，目标价从15美元升至16美元；HC Wainwright & Co.：维持Palvella Therapeutics"买入"评级，目标价从255美元升至270美元
03-25 10:31
BMO Capital Maintains Outperform on TPG, Lowers Price Target to $48
BMO Capital analyst Brennan Hawken maintains TPG (NASDAQ:TPG) with a Outperform and lowers the price target from $60 to $48.
03-25 01:50
One Oracle Indicator Spells Danger But 'I Don't Think It's Going Bankrupt,' Steve Eisman Says
ORCL's credit default swaps remain high due to its $100B+ debt for AI buildout. Billionaire investor 'gulp'ed, but Eisman dismisses bankruptcy risk. Instead, he fears private equity's opaque, highly leveraged credit deals. Blue Owl halted redemptions & liquidated assets due to AI disruption fears.
03-10 01:06
美股大行评级 | 花旗：维持康菲石油"买入"评级！目标价从125美元升至135美元
今日重点评级关注：HC Wainwright & Co.：维持Helus Pharma"买入"评级，目标价从55美元升至95美元；HC Wainwright & Co.：维持Compass Pathways"买入"评级，目标价从40美元升至70美元
03-03 20:22
Barclays Maintains Overweight on TPG, Lowers Price Target to $56
Barclays analyst Eliana Merle maintains TPG (NASDAQ:TPG) with a Overweight and lowers the price target from $69 to $56.
03-02 22:57
美股2月涨跌榜 | AI算力持续井喷引爆光通信概念！Lumentum飙涨近79%，康宁大涨46%
AI算力持续井喷引爆光通信概念！Lumentum飙涨近79%，康宁大涨46%；矿产公司AG涨超53%，美伊局势推动避险情绪升温，现货白银月涨近10%>>
02-28 10:29
美股盘后 | 保罗迪圣电讯优先存托涨9.25%，日月光半导体涨4.82%
保罗迪圣电讯优先存托涨9.25%；日月光半导体涨4.82%；TPG Inc Class A涨3.64%
02-28 07:11
'MarineMax Attracts More Buyout Interest After Donerail Offer, Sources Say' - Reuters Exclusive
Prominent investors show interest in MarineMax as marinas become hot investmentsCompany sent out non disclosure agreementsShareholders vote on directors at next week's annual meetingNEW YORK, Feb 25 (Reuters) - Private
02-25 23:54
美股大行评级 | 潜在涨幅243.25%！泰利克斯制药获花旗升目标价至22.5美元，维持"买入"评级
今日重点评级关注：花旗：维持Telix Pharmaceuticals"买入"评级，目标价从22美元升至22.5美元；摩根士丹利：维持Vir Biotechnology"超配"评级，目标价从20美元升至24美元
02-25 11:03
